![]() |
![]() ![]() | ![]() February
|
| |||||||||||||||||||||||||||||||||||||||||
Questions or Comments regarding this site call 818-980-7476.
This drug, a synthetic version of IgG, is also a very good way to prevent the formation of platelets, and is one of the few drugs that can reduce the rate of platelet aggregation in patients that do not benefit from it. So, a drug that doesn't do much to help those antibiotics patients in the long run could actually help them better. It was originally designed for an autoimmune disease, but studies have already shown that it also works in the blood of patients with conditions such as myocardial infarction, multiple sclerosis, and multiple myeloma and on patients with chronic obstructive pulmonary disease.